Vitiligo: An Autoimmune Skin Disease and Its Immunomodulatory Therapeutic Intervention

    December 2021 in “ Frontiers in Cell and Developmental Biology ”
    Wei‐Ling Chang, W. Robert Lee, Yung‐Che Kuo, Yen‐Hua Huang
    Studysummary This review discusses progress in targeted therapies for vitiligo, focusing on Janus kinase inhibitors and the potential of mesenchymal stem cells, but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Clinical Efficacy of Adipocyte-Derived Stem Cells Conditioned Media Combined with Micro-Injury in Refractory Patch of Alopecia Areata Archives of Dermatological Research · 2021
    2. Hair Follicle Immune Privilege and Its Collapse in Alopecia Areata Experimental dermatology · 2020
    3. Macrophage-Derived Extracellular Vesicle Promotes Hair Growth Cells · 2020
    4. Emerging Topical and Systemic JAK Inhibitors in Dermatology Frontiers in Immunology · 2019
    5. Regulatory T Cells in Autoimmune Skin Diseases Experimental Dermatology · 2018
    6. The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds) Stem Cells International · 2017
    7. Rapid Skin Repigmentation on Oral Ruxolitinib in a Patient with Coexistent Vitiligo and Alopecia Areata Journal of the American Academy of Dermatology · 2015
    8. A Review of Adipocyte Lineage Cells and Dermal Papilla Cells in Hair Follicle Regeneration Journal of Tissue Engineering · 2014